Abstract:BACKGROUND & OBJECTIVE:Axillary lymph node dissection (ALND) is routinely performed during surgery for breast cancer, but whether ALND could increase survival rate of early stage breast cancer patients remains controversial. Recently, replacing ALND with sentinel lymph node (SLN) biopsy has became a hotspot in breast cancer research. This study aimed to evaluate the reliability and accuracy of SLN biopsy for early stage breast cancer, and to discover the significance of multiple step section level cytokeratin immunohistochemistry in identifying micrometastatic disease.METHODS:SLN biopsy was performed on 121 patients with T1 or T2 breast cancer: methylene blue-labeling was used in 38 patients (methylene blue group), double-labeling of (99m)Tc sulfur colloid and methylene blue was used in 83 patients (combination group). Lymphoscintigraphy and hand-hold gamma detector were used to localize SLNs before operation. All SLNs and ALND lymph nodes were pathologically examined. The tumor-negative SLNs were cut at three levels, and detected by immunohistochemistry.RESULTS:Success rates were 81.6% in methylene blue group, and 95.2% in combination group; accurate detection rates of axillary lymph nodes were 93.5% in methylene blue group, and 97.5% in combination group. SLNs were found in 19 patients (23%) by lymphoscintigraphy, and 76 patients (92%) by hand-hold gamma detector, respectively (P=0.04). A total of 194 negative SLNs, detected by routine pathologic examination, were re-examined by multiple step section level cytokeratin immunohistochemistry; micrometastatic diseases were identified in 21 SLNs of 13 patients. The accuracy rate of combined examinations was 98.7%, and the false-negative rate was 3.2%.CONCLUSIONS:The axillary node status can be predicted by SLN biopsy; double-staining is better than methylene blue-labeling. The role of lymphoscintigraphy in SLN biopsy needs further explore. Multiple step section level cytokeratin immunohistochemistry can improve detection rate of micrometastatic diseases.

Prediction of Non-Sentinel Lymph Node Metastases in Breast Cancer

Role of Number of Sentinel Nodes in Predicting Non-Sentinel Node Metastasis in Breast Cancer

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Prediction of Sentinel Lymph Node Biopsy for Axillary Lymph Node Metastasis in Breast Cancer

Prediction on the Axillary Lymph Node Metastasis for Breast Cancer Patients

The Detection and Clinical Significance of Sentinel Lymph Node Biopsy in Breast Cancer

Prediction Value of Sentinel Lymph Nodes Biopsy to the Lymph Node Metastasis in Breast Cancer

Validation of the Memorial Sloan Kettering Cancer Center Nomogram for Predicting Non-Sentinel Lymph Node Metastasis in Sentinel Lymph Node-Positive Breast-Cancer Patients

[Risk Factors of Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients with Positive Sentinel Lymph Node ≤ 2].

[A Nomogram to Predict Non-Sentinel Lymph Node Metastasis for Breast Cancer Patients with Positive Axillary Sentinel Lymph Node].

Intra-operative Radionuclide Lymphatic Mapping in Sentinel Lymph Node Biopsy of Breast Cancer

Factors Predicting Non-Sentinel Lymph Node Status In Breast Cancer Patients With 1-2 Macrometastatic Positive Sentinel Lymph Nodes

[Detection of Sentinel Lymph Node in Patients with Early Stage Breast Cancer].

[Detection of Sentinel Lymph Node in Patients with Breast Cancer].

Predicting the risk of non-sentinel lymph node metastasis in breast cancer patients with 1-2 positive sentinel lymph nodes

Predictive Value of Detection of Sentinel Lymph Nodes on Lymphatic Metastasis of Non-small Cell Lung Cancer

Sentinel lymph node biopsy for breast cancer: a result of 126 cases

Identification of the Sentinel Lymph Node Applied in Breast Cancer

Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Patients with Breast Cancer

Imaging features of sentinel lymph node mapped by multidetector-row computed tomography lymphography in predicting axillary lymph node metastasis

Localization and Evaluation of Sentinel Lymph Node in Breast Cancer from Computed Tomographic Lymphography